Esperion Therapeutics
ESPR
#6841
Rank
$0.48 B
Marketcap
$2.46
Share price
5.58%
Change (1 day)
16.59%
Change (1 year)

Esperion Therapeutics (ESPR) Fails to deliver data

Key failure to deliver metrics for Esperion Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Esperion Therapeutics (ESPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Esperion Therapeutics (ESPR) - since 2013

Volume in USD (price x number of shares), data since 2013

Esperion Therapeutics (ESPR) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024$16.53 M145.14%
2023$6.74 M-17.88%
2022$8.21 M-92.54%
2021$0.11 B-22.56%
2020$0.14 B231.53%
2019$42.87 M-67.65%
2018$0.13 B186.16%
2017$46.31 M130.83%
2016$20.06 M-80.53%
2015$0.10 B663.91%
2014$13.49 M840.1%
2013$1.43 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
$0.87 M$7.6 M๐Ÿ‡บ๐Ÿ‡ธ USA
$7.45 M$23.02 M๐Ÿ‡บ๐Ÿ‡ธ USA
$48.65 M$0.35 B๐Ÿ‡บ๐Ÿ‡ธ USA
$13.62 M$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
$0.43 M$6.21 M๐Ÿ‡บ๐Ÿ‡ธ USA
$1.6 M$20.44 M๐Ÿ‡บ๐Ÿ‡ธ USA